Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -605.61M | -875.31M | -1.18B | -1.28B | -1.18B |
| Total Depreciation and Amortization | 22.09M | 17.69M | 16.18M | 14.31M | 11.49M |
| Total Amortization of Deferred Charges | 10.52M | 10.38M | 10.63M | 11.07M | 11.44M |
| Total Other Non-Cash Items | 100.69M | 181.20M | 339.70M | 396.68M | 292.05M |
| Change in Net Operating Assets | -123.31M | -112.89M | -78.42M | -80.30M | -14.53M |
| Cash from Operations | -595.62M | -778.92M | -895.66M | -935.01M | -883.40M |
| Capital Expenditure | -31.95M | -28.75M | -25.97M | -32.56M | -22.74M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 575.75M | -54.04M | 146.50M | -32.01M | -299.48M |
| Cash from Investing | 543.80M | -82.79M | 120.53M | -64.58M | -322.23M |
| Total Debt Issued | -- | -- | -- | -- | 150.00M |
| Total Debt Repaid | -3.25M | -3.15M | -5.02M | -4.93M | -4.84M |
| Issuance of Common Stock | 117.43M | 127.11M | 959.61M | 959.00M | 938.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -3.74M |
| Cash from Financing | 114.19M | 123.96M | 954.59M | 954.07M | 1.08B |
| Foreign Exchange rate Adjustments | -564.00K | -1.81M | -517.00K | 931.00K | -581.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.80M | -739.56M | 178.94M | -44.59M | -126.69M |